Literature DB >> 5799116

Further studies on the inhibition of monoamine oxidase by M and B 9302 (clorgyline). I. Substrate specificity in various mammalian species.

D W Hall, B W Logan, G H Parsons.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5799116     DOI: 10.1016/0006-2952(69)90258-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  35 in total

1.  In vivo labelling and axonal transport of monoamine oxidase in the rat basal ganglia using radioactive pargyline.

Authors:  J B Gramsbergen; J B Sebens; J Korf
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

2.  Interactions of tricyclic antidepressant drugs with human and rat monoamine oxidase type B.

Authors:  A A Reid; J L Hill; D L Murphy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-12       Impact factor: 3.000

3.  The nature of the electrophoretically separable multiple forms of rat liver monoamine oxidase.

Authors:  M D Houslay; K F Tipton
Journal:  Biochem J       Date:  1973-09       Impact factor: 3.857

4.  A kinetic evaluation of monoamine oxidase activity in rat liver mitochondrial outer membranes.

Authors:  M D Houslay; K F Tipton
Journal:  Biochem J       Date:  1974-06       Impact factor: 3.857

5.  Monoamine oxidase in rat arteries: evidence for different forms and selective localization.

Authors:  J F Coquil; C Goridis; G Mack; N H Neff
Journal:  Br J Pharmacol       Date:  1973-08       Impact factor: 8.739

6.  The inactivation of monamine oxidase by clorgyline (M & B 9302).

Authors:  C J Coulson
Journal:  Biochem J       Date:  1971-02       Impact factor: 3.857

7.  Relationship between the pharmacological and biochemical properties of a monoamine oxidase inhibitor preferentially affecting 5-hydroxytryptamine oxidation.

Authors:  A J Christmas; D W Hall; A Hayward; D R Maxwell
Journal:  Br J Pharmacol       Date:  1970-05       Impact factor: 8.739

8.  Identification of novel catecholamine absorbing proteins in the central nervous system.

Authors:  G M Ross; B E McCarry; S Thakur; R K Mishra
Journal:  J Mol Neurosci       Date:  1993       Impact factor: 3.444

9.  Effect of nonselective and selective inhibitors of monoamine oxidases A and B on pethidine toxicity in mice.

Authors:  R Boden; R Botting; P Coulson; G Spanswick
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

10.  Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat.

Authors:  P Celada; F Artigas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.